Table 2

Maximum grade adverse event per patient (Grade 2–4 only as per CTCAE V.4.0) attributed as possibly, probably, or definitely related to talimogene laherparepvec

ToxicityGrade
234
Anemia320
Diarrhea200
Nausea600
Vomiting420
Chills1810
Leg edema100
Fatigue1930
Fever400
Influenza like symptoms610
Injection site reaction500
Malaise200
Pain510
Skin infection100
Lymphopenia622
Weight loss310
Anorexia110
Back pain100
Generalized muscle weakness210
Pain in extremity330
Dizziness100
Dysgeusia100
Headache210
Neuralgia100
Depression200
Proteinuria010
Renal and urinary disorders100
Hiccups100
Hypertension110
Hypotension100
Total65172
  • CTCAE, Common Terminology Criteria for Adverse Events.